Abstract The low-density lipoprotein receptor-related protein (LRP) is a multifunctional receptor that binds to apolipoprotein E-rich lipoproteins, lipoprotein lipase, a 2 -macroglobulin, lactoferrin, and tissue plasminogen activator. We studied the mRNA expression of LRP in human monocyte-derived macrophages and THP-1 cells. mRNA expression of LRP was induced during cell differentiation from human monocytes to macrophages or after incubation with phorbol ester (tetradecanoylphorbol acetate 100 ng/mL) in THP-1 cells, and the addition of 30 ng/mL macrophage colony-stimulating factor further enhanced LRP expression. These results indicated that the expression of LRP depended L ow-density lipoprotein (LDL) receptor-related protein (LRP), a large cell-surface protein of 4544 amino acids, is a candidate receptor for lipoproteins rich in apolipoprotein (apo) E including chylomicron remnants, /3-very-low-density lipoprotein (/3-VLDL), and hypertrigryceridemic VLDL. 15 The cDNA of LRP was isolated from a library prepared from mouse T lymphocytes, while searching for proteins that share a cysteine-rich repeat sequence that is present in both complement proteins and LDL receptors.
L ow-density lipoprotein (LDL) receptor-related protein (LRP), a large cell-surface protein of 4544 amino acids, is a candidate receptor for lipoproteins rich in apolipoprotein (apo) E including chylomicron remnants, /3-very-low-density lipoprotein (/3-VLDL), and hypertrigryceridemic VLDL. 15 The cDNA of LRP was isolated from a library prepared from mouse T lymphocytes, while searching for proteins that share a cysteine-rich repeat sequence that is present in both complement proteins and LDL receptors. 1 On Northern blot analysis, LRP mRNA (15 kb ) is demonstrated in various tissues and many cultured cells, including spleen, liver, brain, lung, bone marrow, and HepG2 cells. 1 Kristensen et al 6 and Strickland et al 7 simultaneously reported that LRP is the functional receptor for a 2 -macroglobulinproteinase complexes, and Hussaini et al 8 reported that macrophage colony-stimulating factor (M-CSF) increased expression of LRP in a binding study of a 2 -macroglobulin in murine bone marrow macrophages. Furthermore, LRP binds to tissue plasminogen activator, 9 plasminogen activator-inhibitor complexes, 10 lactoferrin, 11 and lipoprotein lipase. 12 The multifunctionality of LRP, through its binding with multiple ligands, suggests its important role in the regulation of many biological events; in particular, the disruption of the LRP gene in mice suggests the essential role of LRP in cell migration, tissue invasion, and remodeling. 13 - 19 The action of M-CSF is mediated by its specific high-affinity receptor encoded by the c-fms proto-oncogene. 20 M-CSF specifically stimulates growth and differentiation of the monocyte-macrophage lineage, enhances many functions of mature monocyte-macrophages, and promotes the production of cytokines. 21 
"
24 M-CSF stimulates clearance of lipoproteins containing apoB-100 via both LDL receptor-dependent and LDL receptor-independent pathways in target tissues of M-CSF. 25 This increased clearance via LDL receptor-independent pathways may be explained by increased expression of LRP in target tissues of M-CSF. In this study, we investigated the mRNA expression of LRP in human monocyte-derived macrophages and THP-1 cells during differentiation and the in vivo effects of M-CSF on mRNA expression of LRP in rabbit tissues. Furthermore, since it is possible that LRP modifies the atherosclerotic process not only through its involvement in lipoprotein metabolism but also through its induction during differentiation and maturation of monocyte-macrophages in the arterial wall, mRNA expression of LRP in the aorta of cholesterol-fed rabbits was studied.
from Nihon Seibutu Zairyo Co, Ltd. Tetradecanoylphorbol acetate (TPA) was obtained from Sigma Chemical Co. All drugs and reagents used were first grade.
Animals and Treatment Procedure
Female Japanese white rabbits (2.5 to 3 kg) were fed water and either normal laboratory chow or chow containing 0.5% cholesterol ad libitum in individual cages; the cholesterol diet was given for 4 weeks. Human M-CSF or saline (400 fig [0.5 mL] IV) was administered to the rabbits by a bolus injection through the marginal ear vein twice a day for 7 consecutive days. After deep anesthesia with pentobarbital sodium (Nembutal; 25 to 30 mg/kg) was induced, a femoral artery was exposed and a 4F Fogarty balloon catheter inserted into the aorta via the left femoral artery. An aortic segment between a point 28 cm cranial to the catheter insertion site and the aortic bifurcation was denuded of its endothelium via balloon catheter injury, as achieved by distension of the balloon three times with saline.
To prepare RNA, on the last day of the M-CSF treatment the animals were killed while under deep anesthesia, and each organ was removed and rapidly frozen in liquid nitrogen. Total RNA was extracted by using the acid guanidinium thiocyanate-phenol-chloroform method according to the method of Chomczynski and Sacchi. 26 
Cell Culture
With a Ficoll-Hypaque gradient method (Lymphoprep, Daiichi Pharmaceutical Co), human monocyte-derived macrophages were prepared by culturing human peripheral monocytes 27 that were isolated from the blood of a normolipidemic healthy donor. The mononuclear cells were recovered from the interface and were washed three times with phosphate-buffered saline (PBS). The washed cells were suspended in RPMI-1640 medium containing 10% (vol/vol) autologous serum with a cell concentration of 3 to 4xlO 6 cells/mL. This cell suspension was seeded into 10-cm dishes and incubated for 2 hours at 37°C under 5% CO 2 . After nonadherent cells were removed, the remaining adherent cells were washed three times with PBS, and culture was continued in a medium containing 10% (vol/ vol) autologous serum. The medium was replaced every 3 or 4 days. M-CSF (30 ng/mL) was added from the beginning of culture. After 10 days of culture, cells were washed three times with PBS, and total RNA was extracted by using the acid guanidinium thiocyanate-phenol-chloroform method. 26 THP-1 cells, obtained from American Type Culture Collection, were seeded in 10-cm dishes with RPMI-1640 containing 10% fetal calf serum and incubated at 37°C under 5% CO 2 . After the indicated time of culture with TPA (100 ng/mL) in the presence or absence of human M-CSF (30 ng/mL), cells were washed three times with PBS, and total RNA was extracted with the acid guanidinium thiocyanate-phenol-chloroform method. 
Northern Blot Analysis
An RNA sample (20 ^ig) was electrophoresed in formaldehyde-agarose (1%) and transferred to a nylon membrane in 10x saline-sodium citrate (SSC; 150 mmol/L NaCl and 10 mmol/L sodium citrate). The filter was prehybridized at 42°C for 3 to 4 hours in buffer (50% formamide and 50% rapid hybridization buffer). The RNA on the membranes was hybridized at 42°C for 20 to 24 hours in the same buffer including the LRP cDNA probe, which was labeled with [ P]dCTP by the method of random-primed DNA labeling. 2829 The filters were washed twice for 15 minutes in 1 x SSC and 0.1% sodium dodecyl sulfate (SDS) at room temperature, twice for 10 minutes in 0.1 x SSC and 0.1% SDS at room temperature, and then air dried and autoradiographed on x-ray film with an intensifying screen at -70°C. The intensity of the band for LRP mRNA was estimated in a Fujix BAS 2000. In each Northern blot analysis, we ensured that the same amount of RNA was applied to each lane of agarose gel by staining the gel with ethidium bromide.
Immunoblot Analysis
Human monocyte-derived macrophages were prepared by culturing human peripheral monocytes as described above. After 9 days of culture with or without 30 ng/mL human M-CSF, the cells were washed three times with PBS and detached mechanically using a cell scraper. The detached cells were centrifuged for 5 minutes at 500g, and the pellet was resuspended in lysis buffer containing 50 mmol/L tris(hydroxymethyl)amimomethane (Tris) maleate, 2 mmol/L CaCl 2 , 1% Triton X-100, and 1 mmol/L phenylmethylsulfonyl fluoride, pH 6.5. The protein contents of the lysates were measured with a bicinchoninic acid protein assay kit (Pierce Chemical Co). 30 Each sample containing 300 ixg protein was adjusted to 1% SDS, 50 mmol/L Tris-HCl, pH 6.8, 10% glycerol, and 0.1% bromophenol blue without heating or adding reducing agent, and the samples were subjected to SDS-polyacrylamide gel electrophoresis (3% to 10% gradient) at 10 mA at room temperature for 20 to 22 hours. After electrophoresis, the samples were electrophoretically transferred from the gel to nitrocellulose membranes in a buffer containing 20 mmol/L Tris base, 150 mmol/L glycine, 0.02% SDS, and 20% methanol at 200 mA for 24 hours. The sheet was immersed in blocking buffer containing 10 mmol/L TrisHCl, 150 mmol/L NaCl, pH 7.4, and 50 mg/mL bovine serum albumin for 1 hour at room temperature and incubated with the same buffer containing anti-LRP serum (4 lAJmL) for 24 hours at 4°C. Polyclonal antibody against rabbit LRP was kindly provided by Dr R.J. Havel. The sheet was then washed twice for 15 minutes with the washing buffer containing 150 mmol/L NaCl, 50 mmol/L Tris-HCl, pH 7.4, 0.1% SDS, 0.2% Nonidet P-40, and 0.25% deoxycholate and incubated in buffer containing 125 I-labeled protein A (2000 cpm/ng, 0.5 jig/mL) for 2 hours at 4°C. The sheet was washed again, air dried, and autoradiographed.
5
Uptake of LDL and 0-VLDL LDL (d= 1.019 to 1.063 g/mL) was prepared from human plasma containing 0.1% EDTA, 0.02% NaN 3 , and 0.5 mg/mL benzamidine from fasted normolipidemic volunteers and was isolated by sequential ultracentrifugation in a 50.2-Ti rotor (Beckman Instruments); /3-VLDL was isolated from 1% cholesterol-fed rabbits by ultracentrifugation. 31 -32 Lipoproteins were radioiodinated with [ 125 I]NaI by using the iodine monochloride method. 33 Human monocyte-derived macrophages (10 6 cells/mL) were cultured with or without 30 ng/mL M-CSF, and cellular degradation of lipoproteins was determined on the third and 10th days of culture. In the LDL degradation experiment the medium was replaced with RPMI-1640 medium containing 5 mg/mL lipoprotein-deficient serum 24 hours before the addition of 1M I-LDL, whereas in the /3-VLDL degradation experiment medium containing 10% autologous serum was used to suppress LDL receptor activity. Thereafter, the cells were cultured with 10 fig/mL iodinated lipoproteins for 5 hours, and degradation of 125 I-lipoproteins in the cells was estimated.
3435 Nonspecific degradation was determined by the addition of a 50-fold excess of unlabeled lipoproteins.
Results

Northern Blot Analysis
We performed Northern blot analysis with a cDNA probe for LRP to investigate the mRNA expression of LRP in human monocyte-derived macrophages and THP-1 cells, a human monocytic cell line. Ethidium bromide staining of agarose gel was performed after electrophoresis to confirm that the same amount of RNA was applied to each lane. See "Methods" for details.
cells (Fig 1) . In THP-1 cells, LRP mRNA was slightly expressed in the nonadhering state before treatment with TPA. Twenty-four hours after treatment with TPA, THP-1 cells clearly expressed LRP mRNA, and this LRP mRNA expression gradually increased during the culture period (Fig 2) . After 4 days of treatment with TPA, the expression of LRP mRNA was enhanced approximately 10.4 -fold compared with that after 24 hours of TPA treatment. Fig 3 shows the time-related changes in mRNA expression of LRP in response to TPA in the presence or absence of M-CSF; M-CSF enhanced the expression of LRP mRNA by 1.7-to 2.9-fold. To determine the effect of human M-CSF on LRP protein expression in human monocyte-derived macrophages, immunoblot analysis in the presence or absence of 30 ng/mL human M-CSF was performed. LRP (580 kD) was detected in macrophages on the ninth day of culture, and the intensity of the LRP band was enhanced 2.5-fold in the presence of M-CSF (Fig 4) . These results indicate that M-CSF stimulated the expression of LRP on the cell surface of human macrophages by stimulating the transcription of LRP. We also obtained a similar enhanced expression of LRP in the presence of M-CSF in calcium blot analysis with 45 Ca (data not shown). 
Effect of M-CSF on the In Vivo Expression of LRP
Human M-CSF (400 ^ig IV) was injected into four Japanese white rabbits for 7 consecutive days to investigate the effect of M-CSF on the expression of LRP mRNA in vivo. On the last day of M-CSF treatment the animals were killed, and each organ was removed.
The mRNA expression of LRP in rabbits treated with M-CSF is shown in Figs 5 and 6 . Liver, lung, and brain are considered to be those organs that express the most LRP.
1 However, we found no significant increase in the expression of LRP mRNA in the liver, lung, and brain of M-CSF-treated animals compared with nontreated animals (Fig 5) , whereas expression of LRP mRNA was significantly enhanced in the spleen by 5.1-fold and slightly in bone marrow by 2.0-fold compared with nontreated animals (Fig 6) . These results indicated that M-CSF enhanced expression of LRP mRNA in target organs of M-CSF.
Four weeks after cholesterol feeding, we evaluated mRNA expression of LRP in the rabbit aorta (n=4) (Fig 7) . The mRNA level was increased in cholesterolfed rabbits 2.6-fold compared with that in rabbits fed normal chow. On the other hand, balloon injury of the aorta did not significantly affect mRNA expression of LRP in either cholesterol-fed or normally fed rabbits. culture. In the presence of acetylated LDL, LRP expression was enhanced 3.8-fold (n=2) compared with the expression in the absence of acetylated LDL (Fig 7) . To know the effects of the atherosclerotic process on the expression of LRP in vascular smooth muscle cells, we studied mRNA expression both in normal medial vascular smooth muscle cells and in smooth muscle cells isolated from the neointima of atherosclerotic aortas of cholesterol-fed rabbits. 36 There was no significant dif200kDa 116kDa 92kDa 66kDa FIG 4 . Immunoblot analysis of low-density lipoprotein receptorrelated protein (LRP) on human monocyte-derived macrophages, which were cultured for 9 days in the presence (+) or absence (-) of 30 ng/mL human macrophage colony-stimulating factor. The cell lysates (300 /zg protein) were subjected to sodium dodecyl sulfate-polyacrylamide (3% to 10%) gel electrophoresis. Proteins were transferred to nitrocellulose paper, which was incubated with an anti-LRP polyclonal antibody and then with ' 25 I-Iabeled protein A, and autoradiography was performed. Molecular mass standards including human apolipoprotein B-100 (550 kDa) are indicated.
LRP 28S
18S
Bone Marrow Spleen In control experiments, total RNA was extracted from the corresponding part of intact aorta after 4 weeks' feeding. We performed the experiment twice; a set of representative results is shown, b, Human monocyte-derived macrophages were cultured for 9 days in the presence or absence (control) of 50 ^g/mL acetylated low-density lipoprotein (LDL), after which total RNA was extracted from the macrophages. The experiment was performed twice. Blot hybridization of RNA extracted from aorta and macrophages was performed with the cDNA probe for low-density lipoprotein receptor-related protein (LRP). RNA (20 ng) was electrophoresed in 1% formaldehyde-agarose. Ethidium bromide staining of agarose gel was performed after electrophoresis to confirm that the same amount of RNA was applied to each lane. See "Methods" for details.
ference in mRNA expression between the two different phenotypes of vascular smooth muscle cells.
Uptake of LDL and 0-VLDL LDL degradation decreased during differentiation and maturation of human monocyte-derived macrophages, and M-CSF enhanced LDL degradation on the 10th day of culture 34 ( Fig 8) . On the other hand, /3-VLDL degradation on the 10th day of culture was significantly greater than that on the third day of culture, indicating that /3-VLDL uptake increased according to cellular differentiation and maturation. Addition of M-CSF further enhanced the uptake of /3-VLDL.
Discussion
We demonstrated the induction of mRNA expression of LRP in human monocyte-derived macrophages during differentiation and maturation and showed that M-CSF further enhanced expression of LRP. Similar induction of LRP expression was also demonstrated in THP-1 cells, the human monocytic cell line, concomitant with the cellular differentiation and maturation after treatment with TPA. TPA is known to induce the production of several proteins, including the scavenger receptor, during cellular differentiation to macrophagelike cells. 37 Therefore, our results suggested that cellular maturation and differentiation of monocyte-macro- 125 l-£-very-low-density lipoprotein (VLDL) in human monocyte-derived macrophages. Human monocyte-derived macrophages were cultured with (+) or without (-) 30 ng/mL macrophage colony-stimulating factor (M-CSF), and cellular degradation of lipoproteins was determined on the third and 10th days of culture. For LDL degradation, the medium was replaced with RPMI-1640 medium containing 5 mgymL lipoprotein-deficient serum 24 hours before the addition of 12S I LDL; for /3-VLDL degradation, medium containing 10% autologous serum was used instead of lipoprotein-deficient serum. Thereafter, the cells were cultured with 10 jig/mL iodinated lipoproteins in the presence (nonspecific degradation) or absence (total degradation) of a 50-fold excess of unlabeled lipoproteins for 5 hours, after which degradation of 125 l-lipoproteins in cells was determined. Specific degradation was determined as the difference between total and nonspecrfic degradation. Each value represents the mean of triplicate wells.
phages are required for induction or full expression of LRP. A similar induction of the scavenger receptor has been reported during differentiation of monocytes to macrophages. 34 Since M-CSF stimulates maturation and differentiation of monocyte-macrophages, the enhanced expression of LRP after M-CSF treatment can be taken to indicate the result of an enhanced process of maturation and differentiation of monocyte-macrophages.
LRP has been identified as an a 2 -macroglobulin receptor from the analysis of cDNA cloning. 6 -7 a 2 -Macroglobulin is considered to be a cytokine-binding plasma protein. 3840 Interleukin-1/3, transforming growth factor-/3, and platelet-derived growth factor bind to a 2 -macroglobulin; these complexes are latent sources of these factors. Hussaini et al 8 have demonstrated the enhanced binding activity of a 2 -macroglobulin receptor of murine bone marrow macrophages in the presence of M-CSF and suggested that the a 2 -macroglobulin receptor/LRP may be involved in a delicately balanced growth regulatory system that includes a r macroglobulin, cytokines, and specific proteinases. Our results were in accordance with their results of binding assay from the viewpoint of the transcriptional expression of LRP in vitro and in vivo.
LRP is thought to be a candidate protein for a specific receptor that removes lipoproteins containing apoE. To demonstrate a correlation between expression of LRP and the cellular uptake of lipoproteins rich in apoE, we compared /3-VLDL degradation with LDL degradation during differentiation and maturation of human monocyte-derived macrophages. LDL receptor expression decreases during cellular differentiation and maturation even in the presence of M-CSF, 34 - 41 whereas in the present study we demonstrated that /3-VLDL degradation increased significantly and M-CSF further enhanced /3-VLDL degradation during cellular differentiation and maturation. This result indicates that when LDL receptor expression is suppressed by the presence of 10% human serum, /3-VLDL is taken up mainly through pathways other than the LDL receptor, such as LRP, although a part of /3-VLDL can be mediated through the LDL receptor that binds to both LDL and /3-VLDL. This result suggests that LRP plays an important role in the uptake of lipoproteins rich in apoE and that M-CSF influences this pathway in matured macrophages.
M-CSF stimulates the clearance of lipoproteins containing apoB-100 via both LDL receptor-dependent and LDL receptor-independent pathways in rabbits. 25 These results suggest that M-CSF may play an important role in the removal of plasma cholesterol. As a mechanism of the increased activity of the LDL receptor-dependent pathway, we have demonstrated an increased expression of LDL receptor in target organs of M-CSF; however, the mechanism of the increased activity of the LDL receptorindependent pathway estimated by the kinetic study with methylated LDL remains to be clarified. 25 We proposed that the LDL receptor-independent pathway might be enhanced in association with proliferation or hypertrophy of target organs of M-CSF, such as the bone marrow and spleen. In the present study, enhanced expression of LRP mRNA in both bone marrow and spleen and the lack of LRP expression in liver were demonstrated after M-CSF treatment. Furthermore, M-CSF increased mRNA expression of LRP in both human monocyte-derived macrophages and THP-1 cells, suggesting that the increased mRNA levels in target tissues of M-CSF might be caused by both tissue hypertrophy and enhanced expression of LRP mRNA in each cell. LRP may function as an LDL receptor-independent pathway that is stimulated after M-CSF treatment. Therefore, M-CSF may reduce the plasma cholesterol level through a mechanism of increased clearance of lipoproteins containing apoE via LRP in target tissues of M-CSF, since rabbit VLDL, intermediate-density lipoprotein, and LDL contain apoE. 42 -43 M-CSF stimulates lipoprotein lipase and apoE secretion from macrophages, 44 -45 stimulates the degradation of acetylated LDL and cholesterol efflux in human monocyte-derived macrophages, 34 and suppresses progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. 46 These results suggest that M-CSF is involved in lipid metabolism of the vascular wall and plays a significant role in the process of atherosclerosis. In addition, M-CSF, which is secreted by vascular cell components including endothelial cells, 16 macrophages,' 7 and smooth muscle cells, 1819 may further modify metabolic events in the vascular wall by regulating the expression of LRP in macrophages.
An early event in the development of atherosclerosis is characterized by the presence of macrophage-derived foam cells in the subendothelial space, 4748 which originate from circulating monocytes. 49 LRP may be induced during this process of differentiation and maturation of monocytes to macrophages and foam cells in the vascular wall and may play a role in the atherosclerotic process. We demonstrated that cholesterol ester enrichment in macrophages in the presence of acetylated LDL enhanced mRNA expression of LRP. In accordance with this observation, cholesterol feeding enhanced the expression of LRP mRNA in the rabbit aorta, although this increased mRNA level may be due not only to an increased expression of LRP in macrophages but also to an increased number of macrophages in the aorta after cholesterol feeding. In fact, microscopic examination demonstrated more macrophages in the aorta of cholesterol-fed rabbits than in control rabbits, whereas no significant increase in the number of macrophages was observed in balloon-injured aorta. Since balloon injury had no effect on mRNA expression of LRP in the aorta even though we observed a significant thickening of both intima and media of the vascular wall (data not shown), the proliferation and phenotypic change of vascular smooth muscle cells were not significantly related to the increased expression of LRP in the aorta of cholesterol-fed rabbits. When we evaluated the mRNA expression in vascular smooth muscle cells isolated from either the neointima of injured aortas or the normal media, 36 we found no significant difference in mRNA expression between two cell types (Y.W. and N.Y., unpublished data, February 1993).
LRP is a multifunctional receptor that can bind to lipoproteins rich in apoE, lipoprotein lipase, 12 a 2 -macroglobulin, tissue plasminogen activator, 9 plasminogen activator-inhibitor complex, 10 and lactoferrin"; thus, it is possible that the LRP induced in human monocytederived macrophages and in the aorta influences the process of atherosclerosis by interacting with these ligands. The interactions of LRP with apoE-rich lipoproteins and lipoprotein lipase may influence lipoprotein uptake in macrophages, and those with a 2 -macroglobulin-protease complexes and urokinase-type plasminogen activator-inhibitor complexes may influence tissue remodeling and cell migration by regulating macrophage functions as Herz et al 13 have suggested.
